ReveonAI Named an OpenAI Select Partner

28 Aug 2026 — ReveonAI, an AI-assisted, expert-led software company for pharma quality and manufacturing, today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network.

The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact.

As an OpenAI Select Partner, ReveonAI will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT-5.6, while using ChatGPT Work to turn ambitious goals into finished work. ReveonAI focuses this capability on pharma quality, manufacturing, and compliance, one of the world's most regulated industries, where documentation is dense and every output must be defensible.

“Every meaningful workflow in pharma quality and manufacturing runs on documentation, and that's where teams get stuck. Being named an OpenAI Select Partner deepens our ability to bring the best of frontier AI into those workflows while our software keeps experts in control of every decision, which is what regulators expect and what quality leaders demand.”

ReveonAI's GMP-native suite — InvestigationAssist, AuditSure, ResponseDraft, DocReview.AI, BatchReview+, and SOPComply+ — is in production across five continents. Built by industry experts with more than 30 years of GMP operations experience behind the product, the software follows a human-in-the-loop model: AI does the heavy lifting of reading, drafting, structuring, and flagging while qualified experts review and approve every output.

Looking ahead, ReveonAI plans to expand its OpenAI-powered offerings across pharma quality and manufacturing workflows and continue scaling its AI skilling programs to help pharmaceutical teams adopt AI responsibly.

Learn more about the OpenAI Partner Network.